This study is not currently recruiting
Description: This study will monitor for potential chronic liver injury and liver fibrosis, in participants treated with cannabidiol oral solution.
Eligibility & Criteria
IRB #: IRB00305459
Principal Investigator: Dr. Eric Chin
Eligible Age Range: 1 year and up
Gender: All
Diagnosis: Currently prescribed or can be prescribed Epidiolex